# Injecting Botulinum Toxin A Underneath the Skin to Treat Spinal Cord Pain in Patients With Spinal Cord Injury

> **NCT02736890** · PHASE2 · TERMINATED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 8 (actual)

## Conditions studied

- Neuropathic Back Pain
- Spinal Cord Injury

## Interventions

- **DRUG:** Botulinum Toxin A
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02736890
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-03
- **Primary completion:** 2018-07-17
- **Final completion:** 2018-07-17
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** funding not available to continue
- **Last updated:** 2019-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02736890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02736890, "Injecting Botulinum Toxin A Underneath the Skin to Treat Spinal Cord Pain in Patients With Spinal Cord Injury". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02736890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*